Navigation Links
New Findings Published In Circulation: Heart Failure Show Potential Utility Of Cardioxyl's HNO Donors As Novel Treatments For Heart Failure
Date:10/28/2013

art failure models. The investigators concluded that the combination of effects differentiates HNO donors from other classes of inotropes or ino-dilators, and provides a strong rationale for continuing studies to develop donors with optimized pharmacology for the treatment of congestive heart failure.

"Cardioxyl is excited about these results obtained with our first-generation HNO donor, and is poised to expand upon this data as we prepare to bring our second-generation HNO donor into the clinic next year," said Chris Kroeger, M.D., Cardioxyl's President and Chief Executive Officer.

The study is available online, via subscription, at http://circheartfailure.ahajournals.org/content/early/2013/10/09/CIRCHEARTFAILURE.113.000632

About Cardioxyl Pharmaceuticals
Cardioxyl Pharmaceuticals is focused on the discovery and development of new classes of safe and effective therapeutic agents for the treatment of cardiovascular disease. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl (HNO) technology. The company's core HNO platform has generated several pre-clinical and clinical candidates. Cardioxyl is a privately held company financed by life science venture investors, including New Enterprise Associates, OrbiMed, Aurora Funds and Osage University Partners.


'/>"/>
SOURCE Cardioxyl Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ARUP Laboratories Presents Recent Findings at PAINWeek
2. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
3. Key Findings: Innovations in Ophthalmic Devices - Anterior Segment
4. Oramed Pharmaceuticals to Present Findings on Oral Insulin to the American Diabetes Association
5. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
6. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
7. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
8. Managed Health Care Associates, Inc. (MHA) Released Results of Sixth Annual Independent Long Term Care Member Study with Expanded Specialty Pharmacy Findings
9. Dr. Kevin Foley to Present DiscGenics Recent Findings at the Lumbar Spine Research Societys Annual Meeting
10. Professional Therapy Associates Study Supports Findings: Physical Therapy Beneficial in Treating Office Workers with Lower Back Pain
11. HemoShear to Present Translational Findings from its Vascular and Liver Human Relevant Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014  BioScrip ® , Inc. (NASDAQ: BIOS ) ... Executive Officer, will present at the Bank of America Merrill Lynch ... , Date: , , , Wednesday, December 3, 2014 , ... , , , Location: , , , Boca Raton Resort ... Inc. BioScrip, Inc. is a leading national ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... 26, 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical ... for infectious diseases, announced today the addition of ... key opinion leader in the areas of pneumonia ... Founder and Chief Executive Officer, ... Opal,s extensive experience investigating bacterial toxins and key ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... WASHINGTON, Aug. 30, 2011 Public Citizen filed a petition ... the FDA should revise its rules that bar generic drug ... drug makers should be allowed to ask the FDA to ... to patients who take their drugs. Reporters developing a story ...
... LAKE FOREST, Ill., Aug. 29, 2011 Hospira, Inc. (NYSE: ... medication delivery company, today announced that it will host an ... 2011. F. Michael Ball, Hospira,s chief executive officer, and several ... event. A streaming audio webcast of the event, ...
Cached Medicine Technology:
(Date:11/26/2014)... The city of San Diego, California, because ... with a plan to recycle wastewater – also called ... supports the San Diego plan as part of her ... Kleyne, by recycling water that San Diego already owns, ... greatly reduced. (Spagat, E, “San Diego looks to sewers ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 With a ... surgeon Dr. Steven Meier has enhanced the user ... current and prospective patients an online destination for orthopedic ... excited to present the new and improved version of ... make it easier than ever for current and prospective ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance for elder ... the adult demographic education and access to computer ... rough seas of applying for Medicaid. Part of this ... of Medicaid eligibility and proper planning, while also helping ... this coverage. , Senior Planning Services has made ...
(Date:11/26/2014)... 26, 2014 Anthropologists have identified ... containing and stopping Ebola, improve international support, and ... systems in West Africa. , The report, ... Ebola: Anthropologists Offer Insights,” will be made public ... Anthropological Association (AAA), Fri., Dec. 5, 11 a.m., ...
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 Bunion ... offering lower prices in an early celebration of the ... Booties are being offered at the promotional price of ... pricing is in addition to any automatic discounts applied ... Bunion Bootie website for complete details. It’s ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2
... is raffling a $100 Super Certificate to one lucky donor every day ... , PHILADELPHIA, Dec. 16 With the holiday season ... and enjoy this special time of year. As we make our plans ... blood. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) ...
... child health data. , ... Boston, MA (Vocus) December ... pregnancy had a 1.5 times higher incidence of asthma when compared ... finds a large population-based study by researchers at Children’s Hospital Boston. ...
... Calif., Dec. 16 Donor mother Kim Morsching will,be among ... Rose Parade,held here on New Year,s Day. This year,s ... make the gift of life possible for others. Kim,Morsching,s ... dying in a tragic accident in 2007. , ...
... AUSTIN, Dec. 16 In this season of giving ... announce that it is,awarding $5.15 million in grants to ... Central Texans. , ... to ensure access to,health care for Central Texans," said ...
... HOUSTON - Lorenzo Cohen, Ph.D., Director of the ... M. D. Anderson Cancer Center is the recipient ... Award of Shanghai Municipality (ISTCASM) and the 2008 ... research into the use of traditional Chinese medicine ...
... 16 Pioneer Surgical Technology,Inc., a leading innovator ... implants and instruments, today announced the closing of ... participation from,InvestMichigan! Growth Capital Fund (IMGCF). Previous investors ... and River Cities,Capital Funds also participated in the ...
Cached Medicine News:Health News:Donating Blood Can Help Fill Your Holiday Stockings 2Health News:Antacid Medication in Pregnancy May Increase Childhood Asthma 2Health News:Antacid Medication in Pregnancy May Increase Childhood Asthma 3Health News:Antacid Medication in Pregnancy May Increase Childhood Asthma 4Health News:Young Athlete's Gift of Life to be Honored on Rose Parade Float 2Health News:$5.15 Million Provided to Support Local Health Care Needs 2Health News:$5.15 Million Provided to Support Local Health Care Needs 3Health News:$5.15 Million Provided to Support Local Health Care Needs 4Health News:M. D. Anderson's Cohen honored for contributions to traditional Chinese medicine 2Health News:M. D. Anderson's Cohen honored for contributions to traditional Chinese medicine 3Health News:Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing 2Health News:Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing 3Health News:Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: